{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:42:35Z","timestamp":1768884155814,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:00:00Z","timestamp":1697241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01213-y","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:02:10Z","timestamp":1697270530000},"page":"4937-4942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety of COVID-19 mRNA vaccination and effects of SARS-CoV-2 infection in children and adults with mast cell disorders"],"prefix":"10.1007","volume":"23","author":[{"given":"Catherine K.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor","family":"Prosty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofianne","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Mul\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Netchiporouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Shand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reman","family":"Hakroush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayelet","family":"Ollech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Miedzybrodzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,14]]},"reference":[{"issue":"11","key":"1213_CR1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420\u20137. https:\/\/doi.org\/10.1182\/blood-2016-09-731893.","journal-title":"Blood"},{"issue":"2","key":"1213_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","volume":"140","author":"C Akin","year":"2017","unstructured":"Akin C. Mast cell activation syndromes. J Allergy Clin Immunol. 2017;140(2):349\u201355. https:\/\/doi.org\/10.1016\/j.jaci.2017.06.007.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1213_CR3","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1016\/j.jaip.2021.05.010","volume":"9","author":"R Kaakati","year":"2021","unstructured":"Kaakati R, Khokhar D, Akin C. Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome. J Allergy Clin Immunol Pract. 2021;9(8):3198\u20139. https:\/\/doi.org\/10.1016\/j.jaip.2021.05.010.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1213_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/all.15476","volume":"78","author":"MP Giannetti","year":"2023","unstructured":"Giannetti MP, Olivieri F, Godwin G, et al. Outcomes of COVID-19 vaccination in 323 patients with clonal and non-clonal mast cell activation disorders. Allergy. 2023;78(1):301\u20134. https:\/\/doi.org\/10.1111\/all.15476.","journal-title":"Allergy"},{"key":"1213_CR5","unstructured":"Immunology CSoAaC. COVID-19 Vaccines FAQ. Accessed July 14, 2023. https:\/\/www.csaci.ca\/covid-19-vaccines-faq\/"},{"issue":"4","key":"1213_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","volume":"47","author":"HA Sampson","year":"2006","unstructured":"Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report\u2013second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. Apr2006;47(4):373\u201380. https:\/\/doi.org\/10.1016\/j.annemergmed.2006.01.018.","journal-title":"Ann Emerg Med"},{"key":"1213_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.12.029","author":"C Zhu","year":"2023","unstructured":"Zhu C, Nguyen A, Prosty C, et al. Safety of COVID-19 mRNA vaccination in children with chronic urticaria (CU). J Allergy Clin Immunol Practice. 2023. https:\/\/doi.org\/10.1016\/j.jaip.2022.12.029.","journal-title":"J Allergy Clin Immunol Practice"},{"key":"1213_CR8","doi-asserted-by":"publisher","DOI":"10.1159\/000530125","author":"H Yuksel Bulut","year":"2023","unstructured":"Yuksel Bulut H, Ulusoy Severcan E, Ertugrul A. COVID-19 vaccines are safely tolerated in adolescents with cutaneous mastocytosis. Int Arch Allergy Immunol. 2023. https:\/\/doi.org\/10.1159\/000530125.","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01213-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01213-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T16:23:05Z","timestamp":1702743785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01213-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":8,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01213-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,14]]},"assertion":[{"value":"23 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EN has been an Advisory Board\/Speaker\/Consultant and\/or received Investigator Initiated Educational and\/or Research funding from AbbVie Inc., Bausch Health, Beiersdorf, Boehringer Ingelheim International, Bristol Myers Squibb, Eli Lilly, Galderma SA., Janssen Inc., LEO Pharma, Medexus, Novartis Pharmaceuticals, Pfizer Inc., Sanofi Genzyme, Sun Pharmaceuticals, and UCB. MB is a consultant for Novartis and Sanofi. The remaining authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all individual participants (or their parents) included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}